Quick Answer
Cellectar Biosciences, Inc. reported Shares Outstanding of 4.24 million shares for fiscal year 2025.
Cellectar Biosciences, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 4.24M | +176.1% |
| 2024 | 1.54M | -92.6% |
| 2023 | 20.74M | +121.0% |
| 2022 | 9.39M | +53.6% |
| 2021 | 6.11M | -86.6% |
| 2020 | 45.44M | +384.1% |
| 2019 | 9.39M | +98.3% |
| 2018 | 4.73M | +184.0% |
| 2017 | 1.67M | -83.9% |
| 2016 | 10.37M | +1108.2% |
| 2015 | 858,140 | +13.5% |
| 2014 | 756,276 | -73.6% |
| 2013 | 2.87M | -93.8% |
| 2012 | 46.40M | +25.7% |
| 2011 | 36.91M | +187.9% |
| 2010 | 12.82M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 3.19M | -92.1% | +76.2% |
| June 30, 2025 | 1.81M | -94.9% | -96.1% |
| March 31, 2025 | 46.08M | +38.9% | +2900.0% |
| December 31, 2024 | 1.54M | -92.6% | -96.2% |
| September 30, 2024 | 40.57M | +309.0% | +13.2% |
| June 30, 2024 | 35.85M | +268.0% | +8.1% |
| March 31, 2024 | 33.16M | +240.5% | +59.9% |
| December 31, 2023 | 20.74M | +121.0% | +109.1% |
- Cellectar Biosciences, Inc. showed an increase of +176.1% in Shares Outstanding compared to the prior fiscal year.
- Over the 2010–2025 period, Cellectar Biosciences, Inc.’s shares outstanding has declined by 66.9% (from 12.82 million shares to 4.24 million shares).
- The most recent figure is from Cellectar Biosciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 4, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: